---
title: "ST JINKE: Dongfang Yinyuan increased its stake by 0.16% to maturity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259080632.md"
description: "ST JINKE announced that the shareholding increase plan of Dongfang Yinyuan Co., Ltd. expired on September 26, 2025. During this period, a total of 16.5633 million shares were increased through centralized bidding in the secondary market, accounting for 0.16% of the company's total share capital, with a transaction amount of 22.7135 million yuan, failing to meet the commitment of not less than 50 million shares for the minimum increase target"
datetime: "2025-09-26T13:10:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259080632.md)
  - [en](https://longbridge.com/en/news/259080632.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259080632.md)
generator: "portal-rs"
---

# ST JINKE: Dongfang Yinyuan increased its stake by 0.16% to maturity

\*ST JINKE announced that the shareholding increase plan of Dongfang Yinyuan Co., Ltd. expired on September 26, 2025. During this period, a total of 16.5633 million shares were increased through centralized bidding in the secondary market, accounting for 0.16% of the company's total share capital, with a transaction amount of 22.7135 million yuan, failing to meet the commitment of not less than 50 million shares for the minimum increase target

### Related Stocks

- [000656.CN](https://longbridge.com/en/quote/000656.CN.md)

## Related News & Research

- [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md)
- [FP Trading Secures UAE Capital Market Authority (CMA) Licence](https://longbridge.com/en/news/296623097.md)
- [HelloGov Launches GovSchema, an Open Standard for How AI Agents Interact with Government Services](https://longbridge.com/en/news/296641682.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [Chromaviso circadian lighting cuts sick leave up to 21%, InnovationsFonden-backed study shows](https://longbridge.com/en/news/296603687.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**